Correlation Between Evogene and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Evogene and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Evogene and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Corvus Pharmaceuticals.
Diversification Opportunities for Evogene and Corvus Pharmaceuticals
-0.88 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Evogene and Corvus is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Evogene i.e., Evogene and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Evogene and Corvus Pharmaceuticals
Given the investment horizon of 90 days Evogene is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Evogene is 1.19 times less risky than Corvus Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 103.00 in Corvus Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 839.00 from holding Corvus Pharmaceuticals or generate 814.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evogene vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| Evogene |
| Corvus Pharmaceuticals |
Evogene and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Corvus Pharmaceuticals
The main advantage of trading using opposite Evogene and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
| Corvus Pharmaceuticals vs. Bright Minds Biosciences | Corvus Pharmaceuticals vs. HP Inc | Corvus Pharmaceuticals vs. Intel | Corvus Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |